Impact of ventilator-associated pneumonia on resource utilization and patient outcome
S. Hugonnet, P. Eggimann, and F. Borst Impact of ventilator-associated pneumonia on resource utilization and patient outcome Infect Control Hosp Epidemiol 25 2004 1090 1096
Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients
M.H. Kollef, G. Sherman, and S. Ward Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 1999 462 474
Nosocomial infections in combined medical-surgical intensive care units in the United States
M.J. Richards, J.R. Edwards, and D.H. Culver Nosocomial infections in combined medical-surgical intensive care units in the United States Infect Control Hosp Epidemiol 21 2000 510 515
Temporal changes in prevalence of anti-microbial resistance in 23 US hospitals
S.K. Fridkin, H.A. Hill, and N.V. Volkova Temporal changes in prevalence of anti-microbial resistance in 23 US hospitals Emerg Infect Dis 8 2002 697 701
Centers for Disease Control and Prevention Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997
Centers for Disease Control and Prevention Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997 MMWR Morb Mortal Wkly Rep 46 1997 813 815
Guidelines for the management of adults with hospital acquired, ventilator-associated and healthcare-associated pneumonia
American Thoracic Society, and Infectious disease society of America
American Thoracic Society, and Infectious disease society of America Guidelines for the management of adults with hospital acquired, ventilator-associated and healthcare-associated pneumonia Am J Respir Crit Care Med 171 2005 388 416
Linezolid vs vancomycin analysis of two double-blind studies of patients with methicillin-resistant staphylococcus aureus nosocomial pneumonia
R.G. Wunderink, J. Rello, and S.K. Cammarata Linezolid vs vancomycin analysis of two double-blind studies of patients with methicillin-resistant staphylococcus aureus nosocomial pneumonia Chest 124 2003 1789 1797
Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant staphylococcus aureus nosocomial pneumonia: A meta-analysis of randomized controlled trials
A.J. Walkey, M.R. O'Donnell, and R. Soylemez Weiner Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials Chest 139 2011 1148 1155
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant staphylococcus aureus
D.L. Stevens, Y. Ma, and D.B. Salmi Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant staphylococcus aureus J Infect Dis 195 2007 202 211
Treatment of gram-positive nosocomial pneumonia: Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin; Nosocomial Pneumonia Group
J. Fagon, H. Patrick, and D.W. Haas Treatment of gram-positive nosocomial pneumonia: prospective randomized comparison of quinupristin/dalfopristin versus vancomycin; Nosocomial Pneumonia Group Am J Respir Crit Care Med 161 2000 753 762